Growth of children born to renal transplanted women

M Isabel S Dinelli1, Erika Ono1, Patrícia O Viana1

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, Federal University of São Paulo, Rua Pedro de Toledo, 781/9°andar, São Paulo, SP, 04039-032, Brazil.

Insights

Infants born to mothers with kidney transplants show high rates of prematurity and low birth weight. However, these children demonstrate significant growth catch-up by one year of age.

Area of Science:

  • Pediatric Nephrology
  • Transplant Medicine
  • Neonatal Development

Background:

  • Neonates born to renal transplant recipients are exposed to immunosuppressive drugs in utero.
  • These infants face increased risks of prematurity and being small for gestational age compared to the general population.

Purpose of the Study:

  • To evaluate the growth trajectory of infants born to renal transplant mothers.
  • To compare the growth of these infants with healthy controls during the first year of life.

Main Methods:

  • Prospective follow-up of 27 infants born to renal transplant mothers and 31 healthy controls.
  • Weight and length measurements recorded at birth and at multiple intervals up to 12 months of age.
  • Analysis of z-scores for weight and length to assess growth deviations.

Main Results:

  • High rates of prematurity (51.9%) and being small for gestational age (40.7%) were observed in the transplant group at birth.
  • At 6 and 12 months of age, infants in the transplant group showed comparable mean weight-for-age and length-for-age z-scores to the control group.
  • No significant differences in growth parameters were noted between the groups by 12 months of age.

Conclusions:

  • Despite initial growth deficits, infants born to renal transplant mothers exhibit catch-up growth during the first year.
  • These findings suggest a positive long-term growth outcome for children born after maternal kidney transplantation.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
442
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
537
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
586
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289